SELENOF and malignant colon neoplasm: In vitro and in vivo studies of Sep15 knockout colon cancer cells or mouse models using systemic knockout Sep15 observed a reversal of colon cancer phenotype and a reduction in the number of chemically induced tumors, respectively [56,57].